Evidence map›Paper›PMID 20177149›Full record

ArticleExperimental & molecular medicine2010

Co-treatment with hepatocyte growth factor and TGF-beta1 enhances migration of HaCaT cells through NADPH oxidase-dependent ROS generation.

Hyun-Ja Nam, Yun-Yeon Park, Gyesoon Yoon, Hyeseong Cho, Jae-Ho Lee

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. The Overactivation of NADPH Oxidase duringAntioxidants (Basel, Switzerland) · 2021
    Article
  4. Isoegomaketone fromEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  5. NOX2 Expression Is Increased in Keratinocytes After Burn Injury.Journal of burn care & research : official publication of the American Burn Association · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hyun-Ja NamDepartment of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon 443-721, Korea.
Yun-Yeon Park
Gyesoon Yoon
Hyeseong Cho
Jae-Ho Lee
Ajou University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wound healing requires re-epithelialization from the wound margin through keratinocyte proliferation and migration, and some growth factors are known to influence this process. In the present study, we found that the co-treatment with hepatocyte growth factor (HGF) and TGF-beta1 resulted in enhanced migration of HaCaT cells compared with either growth factor alone, and that N-acetylcysteine, an antioxidant agent, was the most effective among several inhibitors tested, suggesting the involvement of reactive oxygen species (ROS). Fluorescence-activated cell sorter analysis using 2,7-dichlorofluorescein diacetate (DCF-DA) dye showed an early (30 min) as well as a late (24 h) increase of ROS after scratch, and the increase was more prominent with the growth factor treatment. Diphenyliodonium (DPI), a potent inhibitor of NADPH oxidase, abolished the increase of ROS at 30 min, followed by the inhibition of migration, but not the late time event. More precisely, gene knockdown by shRNA for either Nox-1 or Nox-4 isozyme of gp91phox subunit of NADPH oxidase abolished both the early time ROS production and migration. However, HaCaT cell migration was not enhanced by treatment with H((2))O((2)). Collectively, co-treatment with HGF and TGF-beta1 enhances keratinocyte migration, accompanied with ROS generation through NADPH oxidase, involving Nox-1 and Nox-4 isozymes.

Indexed as

Biphenyl CompoundsCell MovementEpitheliumGene Knockdown TechniquesHepatocyte Growth FactorHumansHydrogen PeroxideIsoenzymesKeratinocytesNADPH Oxidase 1NADPH Oxidase 4NADPH OxidasesOnium CompoundsPhosphatidylinositol 3-KinasesProtein SubunitsReactive Oxygen SpeciesBiphenyl CompoundsdiphenyliodoniumHepatocyte Growth FactorHydrogen PeroxideIsoenzymesNADPH Oxidase 1NADPH Oxidase 4NADPH OxidasesNOX1 protein, humanNOX4 protein, humanOnium CompoundsPhosphatidylinositol 3-KinasesProtein SubunitsReactive Oxygen SpeciesTransforming Growth Factor beta1

Identifiers

PMID20177149
PMCPMC2859326
OpenAlexW2079281946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.